000			02322 a2200673 4500
005			20250516082624.0
264		0	_c20120801
008			201208s 0 0 eng d
022			_a1873-2623
024	7		_a10.1016/j.transproceed.2012.01.038 _2doi
040			_aNLM _beng _cNLM
100	1		_aTanaka, Y
245	0	0	_aOptimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients. _h[electronic resource]
260			_bTransplantation proceedings _cMar 2012
300			_a555-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aBacterial Infections _ximmunology
650	0	4	_aCD4-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCD8-Positive T-Lymphocytes _xdrug effects
650	0	4	_aChi-Square Distribution
650	0	4	_aCommunicable Diseases _ximmunology
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aFluoresceins
650	0	4	_aFluorescent Dyes
650	0	4	_aGraft Rejection _ximmunology
650	0	4	_aGraft Survival _xdrug effects
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aJapan
650	0	4	_aLiver Transplantation _xadverse effects
650	0	4	_aLiving Donors
650	0	4	_aLogistic Models
650	0	4	_aLymphocyte Culture Test, Mixed
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMonitoring, Immunologic _xmethods
650	0	4	_aMultivariate Analysis
650	0	4	_aMycoses _ximmunology
650	0	4	_aPredictive Value of Tests
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSuccinimides
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVirus Diseases _ximmunology
700	1		_aTashiro, H
700	1		_aOnoe, T
700	1		_aIde, K
700	1		_aIshiyama, K
700	1		_aOhdan, H
773	0		_tTransplantation proceedings _gvol. 44 _gno. 2 _gp. 555-9
856	4	0	_uhttps://doi.org/10.1016/j.transproceed.2012.01.038 _zAvailable from publisher's website
999			_c21615228 _d21615228